World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
122
Citations
54126
World Ranking
3481
National Ranking
1915

Overview

Thomas A. Buchholz is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on oncology, with a significant contribution to medicine, particularly in breast cancer treatment and related fields.

The main fields of study for Buchholz include:

  • Medicine

Within medicine, their subfields of study highlight a specialization in:

  • Oncology
  • Cancer Research
  • Pathology and Forensic Medicine
  • Surgery
  • Radiology, Nuclear Medicine and Imaging

The key topics Buchholz has explored encompass:

  • Breast Cancer Treatment Studies
  • Global Cancer Incidence and Screening
  • Lymphoma Diagnosis and Treatment
  • Breast Lesions and Carcinomas
  • Chronic Lymphocytic Leukemia Research
  • Breast Implant and Reconstruction
  • Advances in Oncology and Radiotherapy

Among recent publications associated with Buchholz, the following are notable:

  • Multidisciplinary Management of Locoregional Recurrent Breast Cancer, 2020, Journal of Clinical Oncology

Other recent works in the broader research environment include:

  • Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer, 2020, JAMA Oncology
  • Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation, 2021, International Journal of Radiation Oncology*Biology*Physics
  • Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer, 2024, Journal of Clinical Oncology
  • Organophotocatalytic Aerobic Oxygenation of Phenols in a Visible-Light Continuous-Flow Photoreactor, 2021, Chemistry - A European Journal

Buchholz has frequently collaborated with researchers such as:

  • Kelly K. Hunt
  • Bruce G. Haffty
  • Dirk Klingbiel
  • Joana Parreira
  • Kai Hübel

Their work has appeared predominantly in several scientific venues, including:

  • Journal of Clinical Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Practical Radiation Oncology
  • HemaSphere
  • Orthopaedic Proceedings

Best Publications

  • Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation

    Benjamin D. Smith;Grace L. Smith;Arti Hurria;Gabriel N. Hortobagyi

  • Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

    Aman U. Buzdar;Nuhad K. Ibrahim;Deborah Francis;Daniel J. Booser

  • Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

    Henry M. Kuerer;Lisa A. Newman;Terry L. Smith;Fred C. Ames

  • Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial

    Judy C. Boughey;Vera J. Suman;Elizabeth A. Mittendorf;Gretchen M. Ahrendt

  • Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO).

    Benjamin D. Smith;Benjamin D. Smith;Douglas W. Arthur;Thomas A. Buchholz;Bruce G. Haffty

  • American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

    Harold J. Burstein;Ann Alexis Prestrud;Jerome Seidenfeld;Holly Anderson

  • Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update

    Harold J. Burstein;Harold J. Burstein;Sarah Temin;Holly Anderson;Thomas A. Buchholz

  • WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells

    Wendy A. Woodward;Mercy S. Chen;Fariba Behbod;Maria P. Alfaro

  • Cyclin E and Survival in Patients with Breast Cancer

    Khandan Keyomarsi;Susan L. Tucker;Thomas A. Buchholz;Matthew Callister

  • Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors

    Valentina Guarneri;Kristine Broglio;Shu Wan Kau;Massimo Cristofanilli

  • Neoadjuvant Therapy with Paclitaxel followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Chemotherapy and Concurrent Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: An Update of the Initial Randomized Study Population and Data of Additional Patients Treated with the Same Regimen

    Aman U. Buzdar;Vicente Valero;Nuhad K. Ibrahim;Deborah Francis

  • Risk of Cardiac Death After Adjuvant Radiotherapy for Breast Cancer

    Sharon Hermes Giordano;Yong Fang Kuo;Jean L. Freeman;Thomas A Buchholz

  • Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype.

    W. Fraser Symmans;Caimiao Wei;Rebekah Gould;Xian Yu

  • Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up Study

    Ya-Chen Tina Shih;Ying Xu;Janice Nicole Cormier;Sharon Hermes Giordano

  • High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.

    Ana Maria Gonzalez-Angulo;Jennifer K Litton;Kristine R Broglio;Funda Meric-Bernstam

  • International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

    S. Dawood;S. D. Merajver;P. Viens;P. B. Vermeulen

  • Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer.

    Roman Rouzier;Radhika Rajan;Peter Wagner;Kenneth R. Hess

  • Locoregional Recurrence Patterns After Mastectomy and Doxorubicin-Based Chemotherapy: Implications for Postoperative Irradiation

    Angela Katz;Eric A. Strom;Thomas A. Buchholz;Howard D. Thames

  • Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience.

    Allen M. Chen;Funda Meric-Bernstam;Kelly K. Hunt;Howard D. Thames

  • Invasive Lobular Carcinoma Classic Type: Response to Primary Chemotherapy and Survival Outcomes

    Massimo Cristofanilli;Ana Gonzalez-Angulo;Nour Sneige;Shu Wan Kau

Frequent Co-Authors

Gabriel N. Hortobagyi
Gabriel N. Hortobagyi The University of Texas MD Anderson Cancer Center
Wendy A. Woodward
Wendy A. Woodward The University of Texas MD Anderson Cancer Center
Kelly K. Hunt
Kelly K. Hunt The University of Texas MD Anderson Cancer Center
Henry Mark Kuerer
Henry Mark Kuerer The University of Texas MD Anderson Cancer Center
Sharon H. Giordano
Sharon H. Giordano The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam
Funda Meric-Bernstam The University of Texas MD Anderson Cancer Center
Massimo Cristofanilli
Massimo Cristofanilli Cornell University
Aysegul A. Sahin
Aysegul A. Sahin The University of Texas MD Anderson Cancer Center
Vicente Valero
Vicente Valero The University of Texas MD Anderson Cancer Center
Aman U. Buzdar
Aman U. Buzdar The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine but seeking different or supplementary paths, there are many flexible online degrees related to healthcare. For example, pursuing an online degree in nutrition can lead to rewarding roles in dietetics, wellness coaching, and public health. These programs are ideal for those passionate about food sciences and preventive health.

Healthcare administration is another key area with growing demand. The best mha programs online are designed for professionals aiming to lead hospitals, clinics, or healthcare agencies, providing core leadership and management skills.

For registered nurses seeking advancement without the traditional in-person requirements, some rn to bsn programs no clinicals exist, allowing completion through online coursework. These programs are especially convenient for working professionals.

For those interested in advanced practice and leadership in nursing, accelerated dnp programs online offer a fast-track option to earn a Doctorate of Nursing Practice, opening opportunities in education, administration, or clinical leadership.

Best Scientists Citing Thomas A. Buchholz

Trending Scientists